EUVIMEDEUVIMED entdecken
Crossref

The Impact of p16 Status on Survival Within Non‐Oropharyngeal Head and Neck Squamous Cell Carcinoma

David Ahmadian iD, Charles J Gallego, Camila Hurtado, Phil Tseng, Audrey H Baker, Steven J Wang, Shethal Bearelly

Head & Neck · 2026

DOI: 10.1002/hed.70141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2026. Verfasst von David Ahmadian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Head & Neck Surgery, University of Arizona Department of Otolaryngology, United States. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Cyclin-Dependent Kinase Inhibitor p16, Head and Neck Neoplasms. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HPV‐mediated oropharyngeal cancers have shown improved oncologic outcomes compared to traditional head and neck squamous cell carcinoma (HNSCC). P16, a surrogate marker for HPV, is also overexpressed in non‐oropharyngeal squamous cell carcinoma (non‐OPSCC), but its clinical impact remains unclear. This study evaluates the effect of p16 status in non‐OPSCC.

Methods

A retrospective chart review of non‐OPSCC patients from January 2017 to November 2023 was conducted. Demographics, clinical data, and p16 expression were analyzed. Survival and recurrence rates were compared using Cox regression and Kaplan–Meier with log‐rank testing.

Results

A total of 197 patients with non‐OPSCC were included, most commonly in the oral cavity (55.3%). P16+ tumors were found in 21.8% of cases. Median follow‐up length was similar between groups ( p = 0.724). Tumor recurrence rates were similar ( p = 0.377), and p16+ status did not significantly impact survival.

Conclusions

P16 overexpression in non‐OPSCC does not confer a significant survival advantage or reduced recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckCyclin-Dependent Kinase Inhibitor p16Head and Neck NeoplasmsHumansMaleRetrospective StudiesFemaleMiddle AgedAgedNeoplasm Recurrence, LocalAdultBiomarkers, TumorSurvival RateKaplan-Meier EstimateAged, 80 and over

Stichwörter der Autor:innen

disease‐specific survival (DSS)non‐oropharyngeal squamous cell carcinoma (non‐OPSCC)overall survival (OS)p16 statusprogression‐free survival (PFS)

Substanzen

Cyclin-Dependent Kinase Inhibitor p16CDKN2A protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Head & Neck Surgery, University of Arizona Department of Otolaryngology, United States.

ORCID-Profile: David Ahmadian

Zitieren

APA

Ahmadian, D., Gallego, C. J., Hurtado, C., Tseng, P., Baker, A. H., Wang, S. J., & Bearelly, S. (2026). The Impact of p16 Status on Survival Within Non‐Oropharyngeal Head and Neck Squamous Cell Carcinoma. Head & Neck. https://doi.org/10.1002/hed.70141

Vancouver

Ahmadian D, Gallego CJ, Hurtado C, Tseng P, Baker AH, Wang SJ, et al. The Impact of p16 Status on Survival Within Non‐Oropharyngeal Head and Neck Squamous Cell Carcinoma. Head & Neck. 2026. doi:10.1002/hed.70141

BibTeX
@article{Ahmadian2026,
  author = {Ahmadian, David and Gallego, Charles J and Hurtado, Camila and Tseng, Phil and Baker, Audrey H and Wang, Steven J and Bearelly, Shethal},
  title = {The Impact of p16 Status on Survival Within Non‐Oropharyngeal Head and Neck Squamous Cell Carcinoma},
  journal = {Head & Neck},
  year = {2026},
  doi = {10.1002/hed.70141}
}
Kostenlos starten →